Beside cytogenetics, the most important additional prognostic factors in CLL are CD38 expression, ZAP70 expression, and IGVH@ mutational status, TP53 [17], while novel somatic mutations were identified by high throughput sequencing on currently undergoing further clinical evaluation [19, 20, 40]. This evidence concerns the gene CD38 and B-cell chronic lymphocytic leukemia.